Frontiers in Cardiovascular Medicine (Apr 2022)
Corrigendum: The Prescription Characteristics, Efficacy and Safety of Spironolactone in Real-World Patients With Acute Heart Failure Syndrome: A Prospective Nationwide Cohort Study
- Soo Jin Na,
- Soo Jin Na,
- Jong-Chan Youn,
- Hye Sun Lee,
- Soyoung Jeon,
- Hae-Young Lee,
- Hyun-Jai Cho,
- Jin-Oh Choi,
- Eun-Seok Jeon,
- Sang Eun Lee,
- Min-Seok Kim,
- Jae-Joong Kim,
- Kyung-Kuk Hwang,
- Myeong-Chan Cho,
- Shung Chull Chae,
- Seok-Min Kang,
- Dong-Ju Choi,
- Byung-Su Yoo,
- Kye Hun Kim,
- Byung-Hee Oh,
- Sang Hong Baek
Affiliations
- Soo Jin Na
- Department of Critical Care Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea
- Soo Jin Na
- Department of Medicine, Catholic University Graduate School, Seoul, South Korea
- Jong-Chan Youn
- Division of Cardiology, Department of Internal Medicine, Seoul St. Mary's Hospital, Catholic Research Institute for Intractable Cardiovascular Disease, College of Medicine, The Catholic University of Korea, Seoul, South Korea
- Hye Sun Lee
- Biostatistics Collaboration Unit, Yonsei University College of Medicine, Seoul, South Korea
- Soyoung Jeon
- Biostatistics Collaboration Unit, Yonsei University College of Medicine, Seoul, South Korea
- Hae-Young Lee
- Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea
- Hyun-Jai Cho
- Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea
- Jin-Oh Choi
- Department of Internal Medicine, Sungkyunkwan University College of Medicine, Seoul, South Korea
- Eun-Seok Jeon
- Department of Internal Medicine, Sungkyunkwan University College of Medicine, Seoul, South Korea
- Sang Eun Lee
- Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea
- Min-Seok Kim
- Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea
- Jae-Joong Kim
- Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea
- Kyung-Kuk Hwang
- Department of Internal Medicine, Chungbuk National University College of Medicine, Cheongju, South Korea
- Myeong-Chan Cho
- Department of Internal Medicine, Chungbuk National University College of Medicine, Cheongju, South Korea
- Shung Chull Chae
- Department of Internal Medicine, Kyungpook National University College of Medicine, Daegu, South Korea
- Seok-Min Kang
- 0Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea
- Dong-Ju Choi
- 1Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, South Korea
- Byung-Su Yoo
- 2Department of Internal Medicine, Yonsei University Wonju College of Medicine, Wonju, South Korea
- Kye Hun Kim
- 3Department of Cardiovascular Medicine, Chonnam National University Medical School, Gwangju, South Korea
- Byung-Hee Oh
- 4Department of Internal Medicine, Mediplex Sejong Hospital, Incheon, South Korea
- Sang Hong Baek
- Division of Cardiology, Department of Internal Medicine, Seoul St. Mary's Hospital, Catholic Research Institute for Intractable Cardiovascular Disease, College of Medicine, The Catholic University of Korea, Seoul, South Korea
- DOI
- https://doi.org/10.3389/fcvm.2022.888829
- Journal volume & issue
-
Vol. 9
Abstract
No abstracts available.Keywords
- acute heart failure syndrome
- spironolactone
- mineralocorticoid receptor antagonists
- drug therapy
- outcome